Results

1–10 of 17 results for Inflammation

Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024
Ultra-Widefield Fluorescein Angiography and OCT Findings in Children and Young Adults With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2022
Commercial OCT Enters the Cellular Age – Tracking Macrophage Surveillance of the Macula Circulation!
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2021
Prospective Use of Imaging Quantification of Inflammation: Determining Uveitis Activity and Correlating to Visual Acuity
Jordan D Deaner, MD
Annual Meeting Talks
2021
Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2021
Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated With Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
Annual Meeting Talks
2020
Abicipar Phase 2 MAPLE Trial: Evaluation of All Patients With Post-Injection Inflammation
Tarek S. Hassan, MD, FASRS
Annual Meeting Talks
2020
Topiramate Induced Inflammation and Bilateral Choroidal Detachments
Mudit Tyagi, MS, FASRS
On Demand Cases, Courses, and Papers
2019
Prospective Use of Imaging Quantification of Inflammation: Determining Uveitis Activity and Correlating to Visual Acuity
Jordan D Deaner, MD
Updates from the Field
2021